Aster DM Healthcare Ltd
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]
- Market Cap ₹ 13,042 Cr.
- Current Price ₹ 261
- High / Low ₹ 285 / 168
- Stock P/E 30.7
- Book Value ₹ 89.0
- Dividend Yield 0.00 %
- ROCE 9.09 %
- ROE 10.1 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 4.00% over last quarter.
- Company's median sales growth is 16.4% of last 10 years
Cons
- Stock is trading at 2.93 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 9.81% over last 3 years.
- Company might be capitalizing the interest cost
- Promoters have pledged 98.9% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
1,922 | 2,871 | 3,876 | 5,250 | 5,931 | 6,721 | 7,963 | 8,652 | 8,608 | 10,253 | 11,933 | |
1,660 | 2,421 | 3,370 | 4,805 | 5,582 | 6,089 | 6,886 | 7,187 | 7,506 | 8,720 | 10,368 | |
Operating Profit | 261 | 451 | 506 | 445 | 349 | 632 | 1,077 | 1,465 | 1,103 | 1,533 | 1,565 |
OPM % | 14% | 16% | 13% | 8% | 6% | 9% | 14% | 17% | 13% | 15% | 13% |
11 | 19 | 23 | 25 | 453 | 177 | -155 | -158 | 53 | 51 | 79 | |
Interest | 45 | 48 | 79 | 189 | 371 | 204 | 205 | 391 | 334 | 307 | 329 |
Depreciation | 76 | 111 | 144 | 243 | 322 | 298 | 306 | 586 | 618 | 641 | 780 |
Profit before tax | 151 | 310 | 306 | 38 | 108 | 308 | 410 | 330 | 205 | 637 | 535 |
Tax % | 4% | 9% | 11% | 78% | 10% | 8% | 10% | 5% | 13% | 6% | 11% |
Net Profit | 149 | 284 | 272 | 8 | 98 | 282 | 367 | 315 | 178 | 601 | 475 |
EPS in Rs | 7.26 | 4.69 | 7.00 | 0.20 | 2.52 | 5.32 | 6.59 | 5.54 | 2.96 | 10.53 | 8.51 |
Dividend Payout % | 0% | 35% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 20% |
5 Years: | 12% |
3 Years: | 11% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 22% |
3 Years: | -1% |
TTM: | -19% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 43% |
1 Year: | 31% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 12% |
3 Years: | 10% |
Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
125 | 375 | 389 | 403 | 403 | 505 | 505 | 497 | 497 | 497 | 500 | |
Reserves | 654 | 536 | 1,096 | 17 | 1,472 | 2,327 | 2,709 | 2,775 | 2,875 | 3,456 | 3,949 |
505 | 886 | 1,091 | 3,321 | 2,758 | 2,352 | 2,788 | 5,605 | 4,804 | 4,907 | 5,700 | |
856 | 1,097 | 1,834 | 2,003 | 2,171 | 2,296 | 2,926 | 3,528 | 3,444 | 3,661 | 4,733 | |
Total Liabilities | 2,140 | 2,894 | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,881 |
872 | 1,087 | 2,237 | 2,507 | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,076 | |
CWIP | 185 | 357 | 197 | 358 | 290 | 402 | 550 | 736 | 934 | 998 | 255 |
Investments | 6 | 7 | 3 | 39 | 32 | 38 | 22 | 34 | 63 | 45 | 80 |
1,077 | 1,442 | 1,972 | 2,839 | 2,962 | 3,302 | 4,067 | 4,511 | 3,874 | 4,470 | 5,470 | |
Total Assets | 2,140 | 2,894 | 4,409 | 5,743 | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,881 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,313 | 1,834 | |||
-439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -972 | |||
203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -685 | -817 | |||
Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 45 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 95 | 86 | 83 | 93 | 79 | 84 | 93 | 100 | 86 | 72 | 71 |
Inventory Days | 84 | 71 | 93 | 92 | 102 | 111 | 110 | 138 | 122 | 129 | 135 |
Days Payable | 213 | 176 | 178 | 187 | 151 | 150 | 153 | 303 | 290 | 267 | 309 |
Cash Conversion Cycle | -34 | -18 | -2 | -1 | 30 | 45 | 50 | -65 | -83 | -66 | -102 |
Working Capital Days | 82 | 61 | 69 | 68 | 57 | 59 | 57 | 40 | 38 | 40 | 33 |
ROCE % | 23% | 18% | 7% | 2% | 8% | 14% | 12% | 6% | 11% | 9% |
Documents
Announcements
- Video/Audio Recording Of Earnings Call For The Quarter And Year Ended March 31, 2023 26 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
26 May - Read with SEBI circular no: CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year …
-
Disclosure Under Regulation 23 (9) Of SEBI (LODR) Regulations, 2015
25 May - With reference to the captioned subject, please find enclosed herewith the disclosure of the related party transactions for the half year ended March 31, 2023.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
25 May - With reference to the captioned subject, please find enclosed the Investor Presentation on the Company's performance for the quarter and year ended March 31, 2023. …
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
25 May - With reference to the captioned subject, please find enclosed press release in relation to the audited financial results of the Company for the quarter and …
Annual reports
Concalls
-
May 2023TranscriptNotesPPT REC
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Sep 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptPPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Dec 2020Transcript PPT
-
Nov 2020TranscriptPPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019Transcript PPT
-
Sep 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
May 2019TranscriptPPT
-
Mar 2019TranscriptPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
Network
The Co. is an emerging player in India through its network of 27 hospitals, 120 clinics, 371 pharmacies, 14 labs & 100 patient experience centres as on March 31, 2022. [1]